Elixirr International Plc (ELIX) AI Stock Analysis

• Market Cap: £360.26M
• Dividend Yield: 1.67%
• Average Volume (3M): 149.24K
• Price to Earnings (P/E): 21.7
• Beta (1Y): 1.14
• Revenue Growth: 29.64%
• EPS Growth: -7.27%
• Country: UK
• Employees: 565
• Sector: Industrials
• Sector Strength: 88
• Industry: Consulting Services
• EPS (TTM): 0.35
• Shares Outstanding: 48,187,416
• 10 Day Avg. Volume: 62,456
• 30 Day Avg. Volume: 149,235
• PEG Ratio: 0.67
• Price to Book (P/B): 2.46
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 15.30
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: £925.00
• Price Target Upside: 21.71% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 80 Outperform
• Price Target: 902.00p ▲(18.68%Upside)

Elixirr International Plc is a well-managed company with strong financial fundamentals and a fair valuation. The company's robust financial performance is a key strength, supported by effective cash flow management and a strong balance sheet. The technical analysis presents mixed signals, but the valuation suggests reasonable pricing. Strategic corporate events further bolster the company's growth outlook.

Positive Factors

Financial Performance

Elixirr's strong financial track record continued with revenues up 30% and an adjusted EBITDA margin of 28%.

Growth Strategy

Continued execution of its four-pillar strategy supports revenue growth, including expanding service offerings and successful acquisitions like Hypothesis.

Market Expansion

Plans to move to the LSE Main Market should enhance the investor base and company's profile, with potential inclusion in the FTSE 250.

Negative Factors

Market Expectations

FY24E results are expected to be above market expectations, with revenue greater than £111m.

Elixirr International Plc Business Overview & Revenue Model

Company Description

Elixirr International plc, through its subsidiaries, provides management consultancy services in the United Kingdom, the United States, and internationally. It offers creative, marketing, and self-funded transformation services. The company offers its services for various industries, such as automotive and transportation, manufacturing, business and financial services, charities, energy, utilities and resources, healthcare and pharmaceuticals, insurance, luxury and fashion, travel and leisure, telecommunications, technology, retail and consumer goods, private equity, media, and entertainment and sports industries. Elixirr International plc was founded in 2009 and is headquartered in London, the United Kingdom.

How the Company Makes Money

Elixirr International Plc makes money primarily through providing consulting services to its clients. The company's revenue model is based on fees charged for its expert advisory services, which are typically billed on a time-and-materials basis or through fixed-price contracts. Key revenue streams include strategic consulting projects, digital transformation initiatives, and technology implementation services. Elixirr also benefits from long-term client relationships and repeat business, which contribute significantly to its earnings. Additionally, the company's global reach and expertise across various sectors enable it to secure partnerships and collaborations that enhance its service offerings and revenue potential.

Elixirr International Plc Financial Statement Overview

Summary

Elixirr International Plc demonstrates strong financial performance with robust revenue growth, efficient operations, and solid cash flow management. The company maintains a strong balance sheet with low leverage and high equity, providing financial stability and flexibility.

Income Statement

Elixirr International Plc has demonstrated robust growth in revenue with a year-over-year increase from 2023 to 2024. The company maintains strong profitability, evidenced by a healthy gross profit margin and net profit margin. The EBIT and EBITDA margins indicate efficient operational management. Overall, the income statement reflects a solid and growing company with strong financial performance.

Balance Sheet

The company's balance sheet is strong, with a low debt-to-equity ratio, reflecting prudent financial management. The equity ratio is high, indicating a stable capital structure with significant stockholders' equity relative to total assets. Return on equity remains attractive, showcasing the company's ability to generate returns for shareholders. The company's financial stability is underscored by its solid asset base and manageable liabilities.

Cash Flow

Elixirr International Plc exhibits impressive cash flow management, highlighted by substantial free cash flow growth. The operating cash flow to net income ratio is strong, indicating efficient conversion of income into cash. Free cash flow to net income is well-aligned, signaling effective reinvestment and financial strategy. The cash flow statements reflect a healthy liquidity position and sound financial practices.

Breakdown
Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
111.34M	85.89M	70.70M	50.61M	30.32M
	Gross Profit
35.81M	29.26M	23.16M	17.70M	11.19M
	EBIT
24.57M	22.62M	16.90M	12.38M	6.48M
	EBITDA
27.96M	25.78M	20.02M	14.46M	8.97M
	Net Income Common Stockholders
16.38M	17.24M	12.87M	10.14M	4.79M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
7.53M	18.13M	20.43M	31.80M	17.50M
	Total Assets
175.89M	154.40M	128.66M	107.17M	87.00M
	Total Debt
4.90M	5.36M	5.14M	5.25M	5.29M
	Net Debt
-2.63M	-12.77M	-15.29M	-26.55M	-12.22M
	Total Liabilities
43.78M	34.84M	32.74M	21.13M	16.31M
	Stockholders Equity
132.11M	119.56M	95.92M	86.04M	70.69M
Cash Flow		Free Cash Flow
28.76M	16.67M	15.40M	14.23M	12.12M
	Operating Cash Flow
28.84M	16.79M	15.73M	14.33M	12.15M
	Investing Cash Flow
-21.50M	-14.82M	-18.53M	-3.24M	-1.46M
	Financing Cash Flow
-17.64M	-4.06M	-8.85M	3.11M	3.88M

Elixirr International Plc Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 760.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:ELIX, the sentiment is Neutral. The current price of 760 is below the 20-day moving average (MA) of 799.50, above the 50-day MA of 728.50, and above the 200-day MA of 721.70, indicating a neutral trend. The MACD of 2.66 indicates Positive momentum. The RSI at 44.77 is Neutral, neither overbought nor oversold. The STOCH value of 43.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:ELIX.

Elixirr International Plc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ELIX	80 Outperform	£360.26M	21.72	13.02%	1.67%	29.64%	-7.27%
GFRD	77 Outperform	£401.53M	10.20	35.97%	4.14%	22.39%	179.53%
FNTL	77 Outperform	£286.53M	48.50	5.78%	0.89%	20.65%	-17.11%
WIL	73 Outperform	£309.03M	8.46	14.26%	3.26%	-8.18%	90.18%
Sector *	66 Neutral	$4.51B	12.29	5.40%	3.67%	4.15%	-12.21%
DATA	64 Neutral	£1.35B	46.00	12.82%	1.16%	4.54%	-2.11%
RWA	56 Neutral	£145.16M	29.69	-3.96%	16.04%	-16.16%	-145.46%

Elixirr International Plc Corporate Events

Elixirr International Grants Share Options to Key Executives

Elixirr International plc has announced the grant of share options to key managerial figures, Clare Filby and Christopher Jordan, as part of its unapproved share option plan. These options, which cover a total of 119,048 ordinary shares each, represent approximately 0.49% of the company’s issued share capital and are set at an exercise price of 840p per share with a five-year vesting period. This move is indicative of Elixirr’s strategy to incentivize its leadership team, potentially enhancing its market position and aligning managerial interests with shareholder value.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £850.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Elixirr International to Transition to Main Market, Enhancing Growth Strategy

Elixirr International plc has announced its plans to transition from the AIM to the Main Market of the London Stock Exchange, a move reflecting its growth and ambition. The transition is expected to complete by July 1, 2025, and aims to enhance Elixirr’s market positioning, with the existing AIM listing being canceled. This strategic shift is part of Elixirr’s broader growth strategy, which will be further discussed during their Capital Markets Day event, showcasing their innovative solutions and partnerships.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £850.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Elixirr International Announces Share Transactions and Adjustments

Elixirr International plc announced recent transactions involving its ordinary shares, including the transfer of shares to former shareholders of acquired businesses and a sale by its Non-Executive Chairman. These transactions reflect ongoing adjustments in the company’s shareholding structure, potentially impacting its market positioning and stakeholder interests.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £850.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Elixirr International Announces 2024 Annual Report and Dividend Timetable

Elixirr International plc has announced the posting of its 2024 Annual Report and AGM notice, along with the final dividend timetable for the year ended 31 December 2024. The AGM is scheduled for 24 June 2025, and the final dividend of 11.5p per share will be paid on 20 August 2025. This announcement underscores Elixirr’s commitment to transparency and shareholder engagement, potentially strengthening its market position and stakeholder relations.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £850.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Elixirr International to Host Capital Markets Day Highlighting Growth Strategy

Elixirr International plc is set to host a Capital Markets Day on June 4, 2025, at its London office, inviting institutional investors and analysts to gain insights into its growth strategy and future plans. The event will feature interactive sessions led by global partners, showcasing Elixirr’s innovative digital, data, tech, and AI solutions, including collaborations with Meta and British Cycling, highlighting the company’s commitment to transforming customer experiences and advancing its industry positioning.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £850.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Elixirr International to Host Capital Markets Day on June 4, 2025

Elixirr International plc is set to host a Capital Markets Day on June 4, 2025, at its London office, inviting institutional investors and analysts to gain insights into its growth strategy and future plans. The event will feature interactive sessions with global partners, showcasing Elixirr’s advanced digital, data, tech, and AI solutions, including collaborations with major clients like Meta and British Cycling, highlighting the company’s innovative approach and industry impact.

The most recent analyst rating on (GB:ELIX) stock is a Buy with a £850.00 price target. To see the full list of analyst forecasts on Elixirr International Plc stock, see the GB:ELIX Stock Forecast page.

Elixirr Strengthens Market Position with Strategic Share Acquisition

Elixirr International plc has announced that its Employee Benefit Trust has purchased 308,786 ordinary shares at 780p per share, now holding 3.29% of the company’s issued share capital. This strategic move, guided by Apex Group Fiduciary Services Limited, aims to ensure sufficient shares for employee incentives and new partners, supporting the company’s growth strategy without diluting equity, thereby strengthening its market position.

Elixirr Reports Record FY 2024 Results and Plans Main Market Move

Elixirr International Plc reported a record financial performance for the fiscal year 2024, driven by strong client demand and geographic expansion, with a 30% increase in revenue to £111.3 million. The company plans to move to the Main Market of the London Stock Exchange, which is expected to enhance access to institutional capital and support long-term growth. This strategic move follows significant growth since 2019, including revenue and EBITDA quadrupling and several acquisitions. The company remains confident in its outlook for 2025, supported by high demand for its technology-led advisory services and recent strategic acquisitions, such as the Hypothesis Group, which bolstered its capabilities in the US market.